Low molecular weight heparin was used for anticoagulation.
应用低分子肝素抗凝。
Objective To explore thrombolysis action of low molecular weight heparin (LMWH).
目的探讨低分子肝素(L MWH)的溶栓作用。
Purpose To study purification method of the low molecular weight heparin(LMWH) by affinity chromatography.
目的探索亲和色谱纯化低分子肝素的方法。
Objective To observe the effect of low molecular weight heparin in treating peripheral diabetic vasculopathy.
目的观察低分子肝素钠股动脉注射治疗糖尿病下肢血管病变的疗效。
Objective To study the clinical effects of Xueshuantong with low molecular weight heparin for unstable angina(UA).
目的观察血栓通注射液联合低分子肝素钙治疗不稳定型心绞痛的临床疗效。
To observe the anticoagulation effect of low molecular weight heparin on hemodialysis and to study its related nursing aspect.
观察低分子量肝素在血液透析中的抗凝效果，比较与普通肝素在护理方面的不同处理。
Objective To reduce adverse reactions by way of selecting best hypodermic injection site of low molecular weight heparin sodium.
目的选择皮下注射低分子肝素钠的最佳部位，以减少由于皮下注射低分子肝素钠所引起的不良反应。
Objective: To observe the safety and efficacy of low molecular weight heparin calcic in treatment of type2 diabetic nephropathy.
目的：观察低分子肝素钙对2型糖尿病肾病的疗效和安全性。
AIM To test gelatin microspheres of low molecular weight heparin (LMWH-GMS) release behavior; lung target behavior and stability.
目的考察低分子肝素肺靶向微球缓释性、稳定性和靶向性。
Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulability in acute Kawasaki disease(KD).
目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。
Objective To investigate the effects of the combination of low molecular weight heparin and ACEI on albuminuria in diabetic nephropathy.
目的观察低分子肝素联合血管转换酶抑制剂对糖尿病肾病显性蛋白尿的治疗效果。
Objective to determine the therapeutic effectiveness of low molecular weight heparin calcium in treating unstable angina pectoris (UAP).
目的评价低分子肝素钙治疗不稳定型心绞痛(uap)的效果。
Objective To observe the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of primary nephrotic syndrome.
目的观察低分子量肝素对原发性肾病综合征的治疗作用。
AIM: To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.
目的：观察奥扎格雷钠、低分子肝素钠联合应用治疗进展性脑梗死的临床疗效。
Objective: to investigate the safety of low molecular weight heparin to prevent deep venous thrombosis after primary hip replacement surgery.
目的：研究人工髋关节置换术后使用低分子肝素预防深静脉血栓的安全性。
Objective to determine the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of unstable angina pectoris (UAP).
目的探讨低分子质量肝素(LMWH)治疗不稳定型心绞痛(uap)效果。
Conclusion: low molecular weight heparin calcic is safer and more effective than the control group in the treatment of type 2 diabetic nephropathy.
结论：低分子肝素钙治疗2型糖尿病肾病是安全有效的。
Small dosage of low molecular weight heparin, parenteral nutritional support and somatostatin therapy have the therapeutical effects to some extent.
小剂量低分子肝素、胃肠外营养及生长抑素的联合应用具有较佳的疗效。
Objective To observe the curative effect of different dosages of low molecular weight heparin (LMWH) in patients with acute cerebral infarction (ACI).
目的观察不同剂量低分子肝素(LMWH)对急性脑梗死(aci)患者的疗效。
Objective To evaluate the effects of low molecular weight heparin (LMWH) on serum interleukin-8 (IL-8) in patients with primary nephrotic syndrome (PNS).
目的观察低分子肝素钠对原发性肾病综合征(PNS)患者血浆白介素- 8 (IL - 8)的影响。
Objective: To observe the effect of valsartan and low molecular weight heparin on the proliferation of glomeruli mesangial cells stimulated by high glucose.
目的：探讨缬沙坦和低分子量肝素对高糖刺激大鼠系膜细胞增殖的影响。
AIM: To evaluate the therapeutic effect and safety of low molecular weight heparin calcium combined with naloxone on acute cerebral infraction in early stage.
目的：评价低分子肝素钙联合大剂量纳洛酮治疗早期急性脑梗死的临床疗效和安全性。
Conclusion The low molecular weight heparin is safe and effective in preventing postoperative deep vein thrombosis in patients following hip and knee surgery.
结论低分子肝素能安全、有效地预防髋膝关节术后深静脉血栓形成。
Purpose:To observe the effect of transdermic absorption enhancer of different concentrations on the transdermic absorption of low molecular weight heparin sodium.
目的：考察不同浓度的透皮吸收促进剂对低分子肝素钠透皮吸收的影响。
Conclusion it is quite effective, convenient, safe, economical and commendatory to use aspirin and low molecular weight heparin in acute cerebral infarction therapy.
结论使用肠溶阿司匹林和低分子肝素钙联合治疗急性脑梗塞疗效好，使用简便、安全、经济，可在临床予推广应用。
Results: Both valsartan and low molecular weight heparin could significantly inhibit the proliferation of mesangial cells and when combined the effect was intensified.
结果：缬沙坦和低分子量肝素均可不同程度地抑制高糖刺激系膜细胞增殖，二者合用时作用增强。
Conclusion Low molecular weight heparin combined with routine treatment can control angina pectoris and decrease the incidence of myocardial infarction more effectively.
结论在常规治疗基础上加用低分子肝素钠，能有效控制心绞痛发作，减少心肌梗死发生率。
The immunocompetence of low molecular weight heparin(LMWH) derived from low anticoagulant activity heparin(LAAH), a by-product in commercial heparin production, was studied.
对比研究了低抗凝活性肝素、商品肝素及以低抗凝活性肝素为原料制得的低分子肝素的免疫活性。
The immunocompetence of low molecular weight heparin(LMWH) derived from low anticoagulant activity heparin(LAAH), a by-product in commercial heparin production, was studied.
对比研究了低抗凝活性肝素、商品肝素及以低抗凝活性肝素为原料制得的低分子肝素的免疫活性。
应用推荐